Effect of β-1,6-glucan inhibitors on the invasion process of Candida albicans: Potential mechanism of their in vivo efficacy

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 9, 2009, Pages 3963-3971

  Kitamura, Akihiro ^a   Higuchi, Saito ^a   Hata, Masato ^a   Kawakami, Katsuhiro ^a   Yoshida, Kumi ^a   Namba, Kenji ^a   Nakajima, Ryohei ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BETA 1,6 GLUCAN; CELL MEMBRANE PROTEIN; D 11 2040; D 21 6076; D11 2040; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BIOSYNTHESIS; CANDIDA ALBICANS; CANDIDA GLABRATA; CELL ADHESION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VAGINA CANDIDIASIS;

ANIMALS; ANTIFUNGAL AGENTS; BETA-GLUCANS; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; MICE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; VIRUS INTERNALIZATION;

EID: 70349136266     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00435-09     Document Type: Article

References (39)

1. Albrecht, A., A. Felk, I. Pichova, J. R. Naglik, M. Schaller, P. Groot, D. MacCallum, F. C. Odds, W. Schäfer, F. Klis, M. Monod, and B. Hube. 2006. Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J. Biol. Chem. 281:688-694.
2. Argimón, S., J. A. Wishart, R. Leng, S. Macaskill, A. Mavor, T. Alexandris, S. Nicholls, A. W. Knight, B. Enjalbert, R. Walmsley, F. C. Odds, N. A. Gow, and A. J. Brown. 2007. Developmental regulation of an adhesin gene during cellular morphogenesis in the fungal pathogen Candida albicans. Eukaryot. Cell 6:682-692. (Pubitemid 46697549)
3. Buffo, J., M. A. Herman, and D. R. Soll. 1984. A characterization of pH-regulated dimorphism in Candida albicans. Mycopathologia 85:21-30.
4. Cormack, B. P., N. Ghori, and S. Falkow. 1999. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science 285:578-582.
5. Diekema, D. J., S. A. Messer, A. B. Brueggemann, S. L. Coffman, G. V. Doern, and L. A. Herwaldt. 2002. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J. Clin. Microbiol. 40:1298-1302.
6. Dranginis, A. M., J. M. Rauceo, J. E. Coronado, and P. N. Lipke. 2007. A biochemical guide to yeast adhesins: glycoproteins for social and antisocial occasions. Microbiol. Mol. Biol. Rev. 71:282-294.
7. Fratti, R. A., M. Ghannoum, J. E. Edwards, Jr., and S. G. Filler. 1996. Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect. Immun. 64:4714-4718.
8. Gale, C. A., C. M. Bendel, M. MacCellan, J. M. Becker, J. Berman, and M. K. Hostetter. 1998. Linkage of adhesion, filamentous growth, and virulence in Candida albicans to a single gene, INT1. Science 279:1355-1358. (Pubitemid 28119577)
9. Herrero, A. B., P. Magnelli, M. K. Mansour, S. M. Levitz, H. Bussey, and C. Abeijon. 2004. KRE5 gene null mutant strains of Candida albicans are avirulent and have altered cell wall composition and hypha formation properties. Eukaryot. Cell 3:1423-1432.
10. Imanishi, Y., K. Yokoyama, and K. Nishimura. 2004. Inductions of germ tube and hyphal formations are controlled by mRNA synthesis inhibitor in Candida albicans. Jpn. J. Med. Mycol. 45:113-119. (Pubitemid 38660847)
11. Kitamura, A., K. Someya, M. Hata, R. Nakajima, and M. Takemura. 2009. Discovery of a small-molecule inhibitor of β-1,6-glucan synthesis. Antimicrob. Agents Chemother. 53:670-677.
12. Kumamoto, C. A., and M. D. Vinces. 2005. Alternative Candida albicans lifestyles: growth on surfaces. Annu. Rev. Microbiol. 59:113-133.
13. Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153.
14. Lo, H. J., J. R. Köhler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90:939-949.
15. Lussier, M., A. M. Sdicu, S. Shahinian, and H. Bussey. 1998. The Candida albicans KRE9 gene is required for cell wall beta-1,6-glucan synthesis and is essential for growth on glucose. Proc. Natl. Acad. Sci. USA 95:9825-9830.
16. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348:1546-1554.
17. Mavor, A. L., S. Thewes, and B. Hube. 2005. Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr. Drug Targets 6:863-874.
18. Mio, T., T. Yamada-Okabe, T. Yabe, T. Nakajima, M. Arisawa, and H. Yamada-Okabe. 1997. Isolation of the Candida albicans homologs of Saccharomyces cerevisiae KRE6 and SKN1: expression and physiological function. J. Bacteriol. 179:2363-2372.
19. Nagahashi, S., M. Lussier, and H. Bussey. 1998. Isolation of Candida glabrata homologs of the Saccharomyces cerevisiae KRE9 and KNH1 genes and their involvement in cell wall beta-1,6-glucan synthesis. J. Bacteriol. 180:5020-5029.
20. Nakamata, K., T. Kurita, M. S. A. Bhuiyan, K. Sato, Y. Noda, and K. Yoda. 2007. KEG1/YFR042w encodes a novel Kre6-binding endoplasmic reticulum membrane protein responsible for β-1,6-glucan synthesis in Saccharomyces cerevisiae. J. Biol. Chem. 282:34315-34324. (Pubitemid 350159456)
21. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts, 2nd ed. Approved standard documents M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
22. Nobile, C. J., J. E. Nett, D. R. Andes, and A. P. Mitchell. 2006. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot. Cell 10:1604-1610.
23. Pardini, G., P. W. De Groot, A. T. Coste, M. Karababa, F. M. Klis, C. G. de Koster, and D. Sanglard. 2006. The CRH family coding for cell wall glycosylphosphatidylinositol proteins with a predicted transglycosidase domain affects cell wall organization and virulence of Candida albicans. J. Biol. Chem. 281:40399-40411. (Pubitemid 46041843)
24. Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
25. Roemer, T., S. Delaney, and H. Bussey. 1993. SKN1 and KRE6 define a pair of functional homologs encoding putative membrane proteins involved in beta-glucan synthesis. Mol. Cell. Biol. 13:4039-4048.
26. Rosdy, M., B. A. Bernard, R. Schmidt, and M. Darmon. 1986. Incomplete epidermal differentiation of A431 epidermoid carcinoma cells. In Vitro Cell. Dev. Biol. 22:295-300.
27. Schaller, M., H. C. Korting, C. Borelli, G. Hamm, and B. Hube. 2005. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect. Immun. 73:2758-2765.
28. Shida, H., and R. Ohga. 1990. Effect of resin use in the post-embedding procedure on immunoelectron microscopy of membranous antigens, with special reference to sensitivity. J. Histochem. Cytochem. 38:1687-1691.
29. Sikorski, R. S., and P. Hieter. 1989. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122:19-27.
30. Sobel, J. D., H. C. Wiesenfeld, M. Martens, P. Danna, T. M. Hooton, A. Rompalo, M. Sperling, C. Livengood III, B. Horowitz, J. Von Thron, L. Edwards, H. Panzer, and T. C. Chu. 2004. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N. Engl. J. Med. 351:876-883.
31. Staab, J. F., S. D. Bradway, P. L. Fidel, and P. Sundstrom. 1999. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283:1535-1538.
32. Theiss, S., G. Ishdorj, A. Brenot, M. Kretschmar, C. Y. Lan, T. Nichterlein, J. Hacker, S. Nigam, N. Agabian, and G. A. Köhler. 2006. Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence. Int. J. Med. Microbiol. 296:405-420.
33. Tiballi, R. N., X. He, L. T. Zarins, S. G. Revankar, and C. A. Kauffman. 1995. Use of a colorimetric system for yeast susceptibility testing. J. Clin. Microbiol. 33:915-917.
34. Tkacz, J. S., E. B. Cybulska, and J. O. Lampen. 1971. Specific staining of wall mannan in yeast cells with fluorescein-conjugated concanavalin A. J. Bacteriol. 105:1-5.
35. Toenjes, K. A., S. M. Munsee, A. S. Ibrahim, R. Jeffrey, J. E. Edwards, Jr., and D. I. Johnson. 2005. Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans. Antimicrob. Agents Chemother. 49:963-972.
36. Umeyama, T., A. Kaneko, H. Watanabe, A. Hirai, Y. Uehara, M. Niimi, and M. Azuma. 2006. Deletion of the CaBIG1 gene reduces beta-1,6-glucan synthesis, filamentation, adhesion, and virulence in Candida albicans. Infect. Immun. 74:2373-2381.
37. Vink, E., R. J. Rodriguez-Suarez, M. Gérard-Vincent, J. C. Ribas, H. de Nobel, H. van den Ende, A. Durán, F. M. Klis, and H. Bussey. 2004. An in vitro assay for (136)-beta-D-glucan synthesis in Saccharomyces cerevisiae. Yeast 21:1121-1131.
38. Wakabayashi, H., S. Abe, S. Teraguchi, H. Hayasawa, and H. Yamaguchi. 1998. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds. Antimicrob. Agents Chemother. 42:1587-1591.
39. Zaoutis, T. E., J. Argon, J. Chu, J. A. Berlin, T. J. Walsh, and C. Feudtner. 2005. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin. Infect. Dis. 41:1232-1239.